GSK plc (GSK) Debt by Year
GSK plc carried $19.8B in long-term debt against $4.6B in cash and equivalents at the end of fiscal year 2025. Long-term debt rose 7.9% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters GSK plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GSK Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $19.8B+7.9% | $18.3B-5.4% | $19.4B-5.8% | $20.6B-25.9% | $27.8B-13.2% | $32.0B+2.2% | $31.3B+21.0% | $25.9B+34.1% | $19.3B+6.7% | $18.1B+14.3% | $15.8B |
| Cash & Equivalents | $4.6B-5.7% | $4.8B+29.5% | $3.7B-16.8% | $4.5B-22.1% | $5.8B-32.9% | $8.6B+37.6% | $6.2B+26.3% | $4.9B-4.7% | $5.2B-14.2% | $6.0B-29.7% | $8.6B |
GSK Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2320-F | Q4'2220-F | Q4'2120-F | Q4'2020-F | Q4'1920-F | Q4'1820-F | Q4'1720-F | Q4'1620-F | Q4'1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $19.8B+7.9% | $18.3B-5.4% | $19.4B-5.8% | $20.6B-25.9% | $27.8B-13.2% | $32.0B+2.2% | $31.3B+21.0% | $25.9B+34.1% | $19.3B+6.7% | $18.1B+14.3% | $15.8B |
| Cash & Equivalents | $4.6B-5.7% | $4.8B+29.5% | $3.7B-16.8% | $4.5B-22.1% | $5.8B-32.9% | $8.6B+37.6% | $6.2B+26.3% | $4.9B-4.7% | $5.2B-14.2% | $6.0B-29.7% | $8.6B |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More GSK plc financials
Frequently Asked Questions
What was GSK plc's long-term debt in fiscal year 2025?
GSK plc carried $19.8B in long-term debt against $4.6B in cash and equivalents at the end of fiscal year 2025.
How fast is GSK plc's long-term debt growing?
GSK plc (GSK) long-term debt rose by 7.9% year over year, from $18.3B to $19.8B in fiscal year 2025.
How has GSK plc's long-term debt changed over the years?
Across the 11 fiscal years this page covers, GSK plc (GSK) long-term debt went from $15.8B in fiscal year 2015 to $19.8B in fiscal year 2025.
What was GSK plc's long-term debt in the most recent quarter?
GSK plc (GSK) reported $19.8B in long-term debt in Q4 2025. This represents an increase of 7.9% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what GSK plc (GSK) reported on that line in every period on record.